Navigation Links
Endo Pharmaceuticals Reports Second Quarter Revenues and Updates Financial Guidance, Reflecting the Acquisition of American Medical Systems
Date:8/9/2011

randed Pharmaceuticals$398,267

$  368,840

8%$  773,781

$707,376

9%Total Generics$133,047

$  27,684

381%$267,456

$  53,560

399%Device and ServicesHealthTronics$
49,485

NM$
99,588

NMAMSMen's Health$   9,768

$  —

NM$
9,768

$  —

NMWomen's Health7,787

NM7,787

NMBPH Therapy9,257

NM9,257

NMUterine Health(2)—

NM—

NMSub-total$
26,812

$  —

NM$  26,812

$  —

NMTotal Device and Services$
76,297

$  —

NM$126,400

$  —

NMTotal Revenue$
7,611

$396,524

53%$1,167,637

$760,936

53%(1) To conform to current year presentation, net sales from our non-time released formulation of Opana® have been reclassified and are now included within other branded product results.(2)The uterine health product line, Her Option® was sold in February 2010.  Revenues for 2010 consist of end-customer revenue earned prior to the date of sale, in addition to revenue earned as part of the product supply agreement with CooperSurgical, Inc., which continued through the fourth quarter of 2010.The following table presents Endo's unaudited Net Pro forma Revenues for the six quarters ended June 30, 2011 giving effect to the  AMS acquisition, the Qualitest acquisition, the Penwest acquisition and the HealthTronics, Inc. acquisition as if they had occurred on January 1, 2010 :

Endo Pharmaceuticals Holdings Inc.
Net Pro Forma Revenues (unaudited)
(in thousands)2010

2011Q1

Q2

Q3

Q4

Q1

Q2Branded PharmaceuticalsLIDODERM®

$182,607

$196,090

$196,
'/>"/>

SOURCE Endo Pharmaceuticals
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... , July 30, 2015  ResMed (NYSE: ... signed a definitive agreement to acquire Curative ... ventilation and sleep-disordered breathing medical devices and ... market reputation in China, combined with ResMed,s global leadership in sleep and ... China suffering from ...
(Date:7/30/2015)...  Tandem Diabetes Care®, Inc. (NASDAQ: TNDM ... the t:slim® and t:flex™ Insulin Pumps, today announced ... with Dexcom, Inc. to allow the integration of ... G5 and G6 continuous glucose monitoring ("CGM") systems. ... with Dexcom,s future CGM systems is an important ...
(Date:7/30/2015)... 2015  Unichem Pharmaceuticals ( USA ), ... tablets 25 mg 1000-count bottle to the consumer level. ... due to the identification of a Clopidogrel tablet found ... The risk associated with mistakenly taking a Clopidogrel tablet ... of experiencing Clopidogrel,s side effects which include bleeding and/or ...
Breaking Medicine Technology:ResMed Invests in High-Growth Chinese Sleep and Respiratory Care Market with Curative Medical 2ResMed Invests in High-Growth Chinese Sleep and Respiratory Care Market with Curative Medical 3Tandem Diabetes Care Announces Development Agreement with Dexcom for Integration of Future Generation CGM Systems 2Tandem Diabetes Care Announces Development Agreement with Dexcom for Integration of Future Generation CGM Systems 3Unichem Pharmaceuticals (USA), Inc. Issues a Voluntary Nationwide Recall of Hydrochlorothiazide Tablets Due to the Potential Presence of Foreign Tablets 2
... the Company) (NASDAQ: HOLX ), a leading ... imaging systems and surgical products dedicated to serving the ... (Conceptus) request for an injunction barring future sales of ... and that no royalty will be due to Conceptus ...
... BASIS Science, Inc. ( www.mybasis.com ) the creators of the ... B1 band, will be demoing at the 2012 International CES ... for the first time. The dashboard has been designed as ... health and wellness. "We have designed the Basis ...
Cached Medicine Technology:Hologic Announces Denial of Conceptus' Request for Injunction in Patent Infringement Suit 2Hologic Announces Denial of Conceptus' Request for Injunction in Patent Infringement Suit 3BASIS Science to Demo Basis Band at 2012 International CES; Reveals Design of Web Dashboard 2
(Date:7/30/2015)... ... 30, 2015 , ... In a meaningful ritual intended to symbolize a final ... Center have created an addiction graveyard. Sharing this with the public comes at a ... Rocky Hudson . Hudson (1945-2015) fell in love with the desert when he moved ...
(Date:7/30/2015)... Diego, CA (PRWEB) , ... July 30, 2015 ... ... has been consistently growing into one of the largest, family-owned low cost service ... across residential and commercial applications, as well as growing their company to meet ...
(Date:7/30/2015)... ... July 30, 2015 , ... The need for accessibility ... effort to provide comfort to patients as well as visiting friends and family during ... phone charging stations. , The stations - powered by ChargeItSpot , a Philadelphia-based ...
(Date:7/30/2015)... ... July 30, 2015 , ... The Mesothelioma Applied Research Foundation ... Registry Act of 2015’. The bill was introduced in Congress yesterday by Representatives ... McCollum (D-MN), Joe Kennedy (D-MA), and Leonard Lance (R-NJ). The purpose of the ...
(Date:7/30/2015)... ... July 30, 2015 , ... On July 23rd Clay ... taxpayer money to fund the state’s large prison system, which has amassed largely enough ... rates of incarceration. In light of President Obama’s recent reduction of non violent drug ...
Breaking Medicine News(10 mins):Health News:Serenity Palms Honors Rocky Hudson, an Advocate of AA and a Beloved Resident of Palm Springs 2Health News:Serenity Palms Honors Rocky Hudson, an Advocate of AA and a Beloved Resident of Palm Springs 3Health News:Bill Howe Plumbing, Heating & Air Launches Online Application to Prospective Employees 2Health News:Bill Howe Plumbing, Heating & Air Launches Online Application to Prospective Employees 3Health News:Hospitals Add Phone Charging Stations as an Amenity for Patients and Visitors 2Health News:Bill to Create Patient Registry for Deadly Cancer Introduced in Congress 2Health News:Florida Questions Its Spending on Punitive Incarceration in Light of Exorbitant Costs for Non Violent Offenders 2Health News:Florida Questions Its Spending on Punitive Incarceration in Light of Exorbitant Costs for Non Violent Offenders 3
... decades, hip replacement surgery has been the only treatment for ... younger patients may replace the traditional replacements.// ,Bobby Castor ... in grade school led to a condition called avascular necrosis. ... the hips drive a golf swing, it hurt Castor’s game. ...
... Laboratory research has found evidence that the venom that ... beneficial effects // on some heart problems, strokes, central ... involved the experimental drug ziconotide, a laboratory-made equivalent of ... Magus cone snail, which lives in shallow tropical saltwater. ...
... IGF-1 will increase substantially risks of breast, colon and ... hormone is a disaster waiting to happen. They say ... -- increases levels of insulin-like growth factor 1 (IGF-1). ... can do. ,Currently, human growth hormone is ...
... the drug gabapentin (Neurontin) taken at 2,400 milligrams ... for people with chronic daily headaches. ,Gabapentin is ... its success in treating other pain-related health issues ... Since gabapentin often reduces migraines by more than ...
... analyzed results from a questionnaire that included more than 4,400 ... the annual British Household Panel Survey, began in 1991. Results ... health, but marriage is better for a woman's . ,Researchers ... work out reported much poorer mental health than men who ...
... drug that strongly activates certain systems in the brain.// ... is often addictive. According to the 2000 National Household ... the United States have tried methamphetamine at least once ... methamphetamine users and 18 healthy people to determine how ...
Cached Medicine News:
Optical Urethrotome 8667 for telescope 4 mm, 0. For slitting urethral strictures under vision...
OES Pro Optical Urethrotome...
... With a 4.9mm insertion tube, ... and increases maneuverability even through strictured ... wide viewing angle of 125 in ... a large viewing area and simplifying ...
New technology in optics, processing and application. Laser-welded mechanics in stainless steel provide high safety in sterilization. Saphire windows distal and proximal, validated even for autoclavi...
Medicine Products: